TY - JOUR AU - Fürstenberger, G. AU - Krieg, P. AU - Müller-Decker, K. AU - Habenicht, A. J. R. PY - 2006 DA - 2006// TI - What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? JO - Int J Cancer VL - 119 UR - https://doi.org/10.1002/ijc.22153 DO - 10.1002/ijc.22153 ID - Fürstenberger2006 ER - TY - JOUR AU - Chow, L. W. AU - Loo, W. T. AU - Toi, M. PY - 2005 DA - 2005// TI - Current directions for COX-2 inhibition in breast cancer JO - Biomed Pharmacother VL - 59 UR - https://doi.org/10.1016/S0753-3322(05)80046-0 DO - 10.1016/S0753-3322(05)80046-0 ID - Chow2005 ER - TY - JOUR AU - Ryan, P. D. AU - Goss, P. E. PY - 2006 DA - 2006// TI - Adjuvant hormonal therapy in peri- and postmenopausal breast cancer JO - Oncologist VL - 11 UR - https://doi.org/10.1634/theoncologist.11-7-718 DO - 10.1634/theoncologist.11-7-718 ID - Ryan2006 ER - TY - JOUR AU - Gierach, G. L. PY - 2008 DA - 2008// TI - Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study JO - Breast Cancer Res VL - 10 UR - https://doi.org/10.1186/bcr2089 DO - 10.1186/bcr2089 ID - Gierach2008 ER - TY - JOUR AU - Chandrasekharan, N. V. PY - 2002 DA - 2002// TI - COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression JO - Proc Natl Acad Sci VL - 99 UR - https://doi.org/10.1073/pnas.162468699 DO - 10.1073/pnas.162468699 ID - Chandrasekharan2002 ER - TY - JOUR AU - Garavito, R. M. AU - Mulichak, A. M. PY - 2003 DA - 2003// TI - The structure of mammalian cyclooxygenases JO - Annu Rev Biophys Biomol Struct VL - 32 UR - https://doi.org/10.1146/annurev.biophys.32.110601.141906 DO - 10.1146/annurev.biophys.32.110601.141906 ID - Garavito2003 ER - TY - JOUR AU - Kaduce, T. L. AU - Figard, P. H. AU - Leifur, R. AU - Spector, A. A. PY - 1989 DA - 1989// TI - Formation of 9-hydroxyoctadecadienoic acid from linoleic acid in endothelial cells JO - J Biol Chem VL - 264 ID - Kaduce1989 ER - TY - JOUR AU - Chan, B. S. AU - Satriano, J. A. AU - Pucci, M. AU - Schuster, V. L. PY - 1998 DA - 1998// TI - Mechanism of prostaglandin E2 transport across the plasma membrane of HeLa cells and Xenopus oocytes expressing the prostaglandin transporter "PGT" JO - J Biol Chem VL - 273 UR - https://doi.org/10.1074/jbc.273.12.6689 DO - 10.1074/jbc.273.12.6689 ID - Chan1998 ER - TY - JOUR AU - Ushikubi, F. PY - 1998 DA - 1998// TI - Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3 JO - Nature VL - 395 UR - https://doi.org/10.1038/26233 DO - 10.1038/26233 ID - Ushikubi1998 ER - TY - JOUR AU - Sugimoto, Y. AU - Segi, E. AU - Tsuboi, K. AU - Ichikawa, A. AU - Narumiya, S. PY - 1998 DA - 1998// TI - Female reproduction in mice lacking the prostaglandin F receptor. Roles of prostaglandin and oxytocin receptors in parturition JO - Adv Exp Med Biol VL - 449 UR - https://doi.org/10.1007/978-1-4615-4871-3_39 DO - 10.1007/978-1-4615-4871-3_39 ID - Sugimoto1998 ER - TY - JOUR AU - Murata, T. PY - 1997 DA - 1997// TI - Altered pain perception and inflammatory response in mice lacking prostacyclin receptor JO - Nature VL - 388 UR - https://doi.org/10.1038/41780 DO - 10.1038/41780 ID - Murata1997 ER - TY - JOUR AU - Lim, H. PY - 1999 DA - 1999// TI - Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta JO - Genes Dev VL - 13 UR - https://doi.org/10.1101/gad.13.12.1561 DO - 10.1101/gad.13.12.1561 ID - Lim1999 ER - TY - JOUR AU - Coleman, R. A. AU - Smith, W. L. AU - Narumiya, S. PY - 1994 DA - 1994// TI - International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes JO - Pharmacol Rev VL - 46 ID - Coleman1994 ER - TY - JOUR AU - Narumiya, S. AU - Sugimoto, Y. AU - Ushikubi, F. PY - 1999 DA - 1999// TI - Prostanoid receptors: structures, properties, and functions JO - Physiol Rev VL - 79 ID - Narumiya1999 ER - TY - JOUR AU - Dubois, R. N. PY - 1998 DA - 1998// TI - Cyclooxygenase in biology and disease JO - FASEB J VL - 12 ID - Dubois1998 ER - TY - JOUR AU - Lydford, S. J. AU - McKechnie, K. C. AU - Dougall, I. G. PY - 1996 DA - 1996// TI - Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery JO - Br J Pharmacol VL - 117 UR - https://doi.org/10.1111/j.1476-5381.1996.tb15148.x DO - 10.1111/j.1476-5381.1996.tb15148.x ID - Lydford1996 ER - TY - JOUR AU - Funk, C. D. PY - 1993 DA - 1993// TI - Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype JO - J Biol Chem VL - 268 ID - Funk1993 ER - TY - JOUR AU - Sharif, N. A. AU - Davis, T. L. PY - 2002 DA - 2002// TI - Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques JO - J Pharm Pharmacol VL - 54 UR - https://doi.org/10.1211/0022357021778655 DO - 10.1211/0022357021778655 ID - Sharif2002 ER - TY - JOUR AU - An, S. AU - Yang, J. AU - Xia, M. AU - Goetzl, E. J. PY - 1993 DA - 1993// TI - Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2 JO - Biochem Biophys Res Commun VL - 197 UR - https://doi.org/10.1006/bbrc.1993.2470 DO - 10.1006/bbrc.1993.2470 ID - An1993 ER - TY - JOUR AU - Yang, J. AU - Xia, M. AU - Goetzl, E. J. AU - An, S. PY - 1994 DA - 1994// TI - Cloning and expression of the EP3-subtype of human receptors for prostaglandin E2 JO - Biochem Biophys Res Commun VL - 198 UR - https://doi.org/10.1006/bbrc.1994.1142 DO - 10.1006/bbrc.1994.1142 ID - Yang1994 ER - TY - JOUR AU - Bastien, L. AU - Sawyer, N. AU - Grygorczyk, R. AU - Metters, K. M. AU - Adam, M. PY - 1994 DA - 1994// TI - Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype JO - J Biol Chem VL - 269 ID - Bastien1994 ER - TY - JOUR AU - Batshake, B. AU - Nilsson, C. AU - Sundelin, J. PY - 1995 DA - 1995// TI - Molecular characterization of the mouse prostanoid EP1 receptor gene JO - Eur J Biochem VL - 231 UR - https://doi.org/10.1111/j.1432-1033.1995.tb20765.x DO - 10.1111/j.1432-1033.1995.tb20765.x ID - Batshake1995 ER - TY - JOUR AU - Regan, J. W. PY - 1994 DA - 1994// TI - Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype JO - Mol Pharmacol VL - 46 ID - Regan1994 ER - TY - JOUR AU - Hizaki, H. PY - 1999 DA - 1999// TI - Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2) JO - Proc Natl Acad Sci USA VL - 96 UR - https://doi.org/10.1073/pnas.96.18.10501 DO - 10.1073/pnas.96.18.10501 ID - Hizaki1999 ER - TY - JOUR AU - Sheller, J. R. AU - Mitchell, D. AU - Meyrick, B. AU - Oates, J. AU - Breyer, R. PY - 2000 DA - 2000// TI - EP(2) receptor mediates bronchodilation by PGE(2) in mice JO - J Appl Physiol VL - 88 ID - Sheller2000 ER - TY - JOUR AU - Boie, Y. PY - 1997 DA - 1997// TI - Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes JO - Eur J Pharmacol VL - 340 UR - https://doi.org/10.1016/S0014-2999(97)01383-6 DO - 10.1016/S0014-2999(97)01383-6 ID - Boie1997 ER - TY - JOUR AU - Katsuyama, M. PY - 1995 DA - 1995// TI - The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and northern blot analysis JO - FEBS Lett VL - 372 UR - https://doi.org/10.1016/0014-5793(95)00966-D DO - 10.1016/0014-5793(95)00966-D ID - Katsuyama1995 ER - TY - JOUR AU - Kotani, M. PY - 1997 DA - 1997// TI - Structural organization of the human prostaglandin EP3 receptor subtype gene (PTGER3) JO - Genomics VL - 40 UR - https://doi.org/10.1006/geno.1996.4585 DO - 10.1006/geno.1996.4585 ID - Kotani1997 ER - TY - JOUR AU - Namba, T. PY - 1993 DA - 1993// TI - Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity JO - Nature VL - 365 UR - https://doi.org/10.1038/365166a0 DO - 10.1038/365166a0 ID - Namba1993 ER - TY - JOUR AU - Aoki, J. PY - 1999 DA - 1999// TI - Signal transduction pathway regulating prostaglandin EP3 receptor-induced neurite retraction: requirement for two different tyrosine kinases JO - Biochem J VL - 340 UR - https://doi.org/10.1042/bj3400365 DO - 10.1042/bj3400365 ID - Aoki1999 ER - TY - JOUR AU - Audoly, L. P. PY - 1999 DA - 1999// TI - Prostaglandin E-prostanoid-3 receptor activation of cyclic AMP response element-mediated gene transcription JO - J Pharmacol Exp Ther VL - 289 ID - Audoly1999 ER - TY - JOUR AU - Hasegawa, H. AU - Negishi, M. AU - Ichikawa, A. PY - 1996 DA - 1996// TI - Two isoforms of the prostaglandin E receptor EP3 subtype different in agonist-independent constitutive activity JO - J Biol Chem VL - 271 UR - https://doi.org/10.1074/jbc.271.4.1857 DO - 10.1074/jbc.271.4.1857 ID - Hasegawa1996 ER - TY - JOUR AU - Audoly, L. P. PY - 2001 DA - 2001// TI - Role of EP(2) and EP(3) PGE(2) receptors in control of murine renal hemodynamics JO - Am J Physiol Heart Circ Physiol VL - 280 ID - Audoly2001 ER - TY - JOUR AU - Fabre, J. E. PY - 2001 DA - 2001// TI - Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation JO - J Clin Invest VL - 107 UR - https://doi.org/10.1172/JCI10881 DO - 10.1172/JCI10881 ID - Fabre2001 ER - TY - JOUR AU - Sugimoto, Y. AU - Narumiya, S. AU - Ichikawa, A. PY - 2000 DA - 2000// TI - Distribution and function of prostanoid receptors: studies from knockout mice JO - Prog Lipid Res VL - 39 UR - https://doi.org/10.1016/S0163-7827(00)00008-4 DO - 10.1016/S0163-7827(00)00008-4 ID - Sugimoto2000 ER - TY - JOUR AU - Kiriyama, M. PY - 1997 DA - 1997// TI - Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells JO - Br J Pharmacol VL - 122 UR - https://doi.org/10.1038/sj.bjp.0701367 DO - 10.1038/sj.bjp.0701367 ID - Kiriyama1997 ER - TY - JOUR AU - Kay, A. B. AU - Barata, L. AU - Meng, Q. AU - Durham, S. R. AU - Ying, S. PY - 1997 DA - 1997// TI - Eosinophils and eosinophil-associated cytokines in allergic inflammation JO - Int Arch Allergy Immunol VL - 113 UR - https://doi.org/10.1159/000237545 DO - 10.1159/000237545 ID - Kay1997 ER - TY - JOUR AU - Hayaishi, O. PY - 2000 DA - 2000// TI - Molecular mechanisms of sleep-wake regulation: a role of prostaglandin D2 JO - Philos Trans R Soc Lond B Biol Sci VL - 355 UR - https://doi.org/10.1098/rstb.2000.0564 DO - 10.1098/rstb.2000.0564 ID - Hayaishi2000 ER - TY - JOUR AU - Eguchi, N. PY - 1999 DA - 1999// TI - Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice JO - Proc Natl Acad Sci USA VL - 96 UR - https://doi.org/10.1073/pnas.96.2.726 DO - 10.1073/pnas.96.2.726 ID - Eguchi1999 ER - TY - JOUR AU - Boie, Y. AU - Sawyer, N. AU - Slipetz, D. M. AU - Metters, K. M. AU - Abramovitz, M. PY - 1995 DA - 1995// TI - Molecular cloning and characterization of the human prostanoid DP receptor JO - J Biol Chem VL - 270 UR - https://doi.org/10.1074/jbc.270.32.18910 DO - 10.1074/jbc.270.32.18910 ID - Boie1995 ER - TY - JOUR AU - Nagata, K. PY - 1999 DA - 1999// TI - CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s) JO - FEBS Lett VL - 459 UR - https://doi.org/10.1016/S0014-5793(99)01251-X DO - 10.1016/S0014-5793(99)01251-X ID - Nagata1999 ER - TY - JOUR AU - Norel, X. PY - 1999 DA - 1999// TI - Prostanoid receptors involved in the relaxation of human bronchial preparations JO - Br J Pharmacol VL - 126 UR - https://doi.org/10.1038/sj.bjp.0702392 DO - 10.1038/sj.bjp.0702392 ID - Norel1999 ER - TY - JOUR AU - Walch, L. PY - 1999 DA - 1999// TI - Prostanoid receptors involved in the relaxation of human pulmonary vessels JO - Br J Pharmacol VL - 126 UR - https://doi.org/10.1038/sj.bjp.0702393 DO - 10.1038/sj.bjp.0702393 ID - Walch1999 ER - TY - JOUR AU - Hirai, H. PY - 2001 DA - 2001// TI - Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2 JO - J Exp Med VL - 193 UR - https://doi.org/10.1084/jem.193.2.255 DO - 10.1084/jem.193.2.255 ID - Hirai2001 ER - TY - JOUR AU - Monneret, G. AU - Gravel, S. AU - Diamond, M. AU - Rokach, J. AU - Powell, W. S. PY - 2001 DA - 2001// TI - Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor JO - Blood VL - 98 UR - https://doi.org/10.1182/blood.V98.6.1942 DO - 10.1182/blood.V98.6.1942 ID - Monneret2001 ER - TY - JOUR AU - Horton, E. W. AU - Poyser, N. L. PY - 1976 DA - 1976// TI - Uterine luteolytic hormone: a physiological role for prostaglandin F2alpha JO - Physiol Rev VL - 56 ID - Horton1976 ER - TY - JOUR AU - Barnard, J. W. AU - Ward, R. A. AU - Taylor, A. E. PY - 1992 DA - 1992// TI - Evaluation of prostaglandin F2 alpha and prostacyclin interactions in the isolated perfused rat lung JO - J Appl Physiol VL - 72 ID - Barnard1992 ER - TY - JOUR AU - Adams, J. W. PY - 1996 DA - 1996// TI - Prostaglandin F2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes JO - J Biol Chem VL - 271 UR - https://doi.org/10.1074/jbc.271.2.1179 DO - 10.1074/jbc.271.2.1179 ID - Adams1996 ER - TY - JOUR AU - Abramovitz, M. PY - 1994 DA - 1994// TI - Cloning and expression of a cDNA for the human prostanoid FP receptor JO - J Biol Chem VL - 269 ID - Abramovitz1994 ER - TY - JOUR AU - Pierce, K. L. AU - Fujino, H. AU - Srinivasan, D. AU - Regan, J. W. PY - 1999 DA - 1999// TI - Activation of FP prostanoid receptor isoforms leads to Rho-mediated changes in cell morphology and in the cell cytoskeleton JO - J Biol Chem VL - 274 UR - https://doi.org/10.1074/jbc.274.50.35944 DO - 10.1074/jbc.274.50.35944 ID - Pierce1999 ER - TY - JOUR AU - Muller, K. AU - Krieg, P. AU - Marks, F. AU - Furstenberger, G. PY - 2000 DA - 2000// TI - Expression of PGF(2alpha) receptor mRNA in normal, hyperplastic and neoplastic skin JO - Carcinogenesis VL - 21 UR - https://doi.org/10.1093/carcin/21.5.1063 DO - 10.1093/carcin/21.5.1063 ID - Muller2000 ER - TY - JOUR AU - Nakajima, T. PY - 2003 DA - 2003// TI - New Fluoroprostaglandin F(2alpha) Derivatives with Prostanoid FP-Receptor Agonistic Activity as Potent Ocular-Hypotensive Agents JO - Biol Pharm Bull VL - 26 UR - https://doi.org/10.1248/bpb.26.1691 DO - 10.1248/bpb.26.1691 ID - Nakajima2003 ER - TY - JOUR AU - Bunting, S. AU - Gryglewski, R. AU - Moncada, S. AU - Vane, J. R. PY - 1976 DA - 1976// TI - Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation JO - Prostaglandins VL - 12 UR - https://doi.org/10.1016/0090-6980(76)90125-8 DO - 10.1016/0090-6980(76)90125-8 ID - Bunting1976 ER - TY - JOUR AU - Moncada, S. PY - 1982 DA - 1982// TI - Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin JO - Br J Pharmacol VL - 76 UR - https://doi.org/10.1111/j.1476-5381.1982.tb09186.x DO - 10.1111/j.1476-5381.1982.tb09186.x ID - Moncada1982 ER - TY - JOUR AU - Moncada, S. AU - Higgs, E. A. AU - Vane, J. R. PY - 1977 DA - 1977// TI - Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation JO - Lancet VL - 1 UR - https://doi.org/10.1016/S0140-6736(77)91655-5 DO - 10.1016/S0140-6736(77)91655-5 ID - Moncada1977 ER - TY - JOUR AU - Vane, J. R. AU - Botting, R. M. PY - 1995 DA - 1995// TI - Pharmacodynamic profile of prostacyclin JO - Am J Cardiol VL - 75 UR - https://doi.org/10.1016/S0002-9149(99)80377-4 DO - 10.1016/S0002-9149(99)80377-4 ID - Vane1995 ER - TY - JOUR AU - Smith, W. L. AU - DeWitt, D. L. AU - Garavito, R. M. PY - 2000 DA - 2000// TI - Cyclooxygenases: structural, cellular, and molecular biology JO - Annu Rev Biochem VL - 69 UR - https://doi.org/10.1146/annurev.biochem.69.1.145 DO - 10.1146/annurev.biochem.69.1.145 ID - Smith2000 ER - TY - JOUR AU - McAdam, B. F. PY - 1999 DA - 1999// TI - Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2 JO - Proc Natl Acad Sci USA VL - 96 UR - https://doi.org/10.1073/pnas.96.1.272 DO - 10.1073/pnas.96.1.272 ID - McAdam1999 ER - TY - JOUR AU - Catella-Lawson, F. PY - 1999 DA - 1999// TI - Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids JO - J Pharmacol Exp Ther VL - 289 ID - Catella-Lawson1999 ER - TY - JOUR AU - Brock, T. G. AU - McNish, R. W. AU - Peters-Golden, M. PY - 1999 DA - 1999// TI - Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2 JO - J Biol Chem VL - 274 UR - https://doi.org/10.1074/jbc.274.17.11660 DO - 10.1074/jbc.274.17.11660 ID - Brock1999 ER - TY - JOUR AU - Armstrong, R. A. AU - Lawrence, R. A. AU - Jones, R. L. AU - Wilson, N. H. AU - Collier, A. PY - 1989 DA - 1989// TI - Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors JO - Br J Pharmacol VL - 97 UR - https://doi.org/10.1111/j.1476-5381.1989.tb12001.x DO - 10.1111/j.1476-5381.1989.tb12001.x ID - Armstrong1989 ER - TY - JOUR AU - Namba, T. PY - 1994 DA - 1994// TI - cDNA cloning of a mouse prostacyclin receptor. Multiple signaling pathways and expression in thymic medulla JO - J Biol Chem VL - 269 ID - Namba1994 ER - TY - JOUR AU - Breyer, R. M. AU - Bagdassarian, C. K. AU - Myers, S. A. AU - Breyer, M. D. PY - 2001 DA - 2001// TI - Prostanoid receptors: subtypes and signaling JO - Annu Rev Pharmacol Toxicol VL - 41 UR - https://doi.org/10.1146/annurev.pharmtox.41.1.661 DO - 10.1146/annurev.pharmtox.41.1.661 ID - Breyer2001 ER - TY - JOUR AU - Smyth, E. M. AU - Austin, S. C. AU - Reilly, M. P. AU - FitzGerald, G. A. PY - 2000 DA - 2000// TI - Internalization and sequestration of the human prostacyclin receptor JO - J Biol Chem VL - 275 UR - https://doi.org/10.1074/jbc.M003873200 DO - 10.1074/jbc.M003873200 ID - Smyth2000 ER - TY - JOUR AU - Dorn, G. W. AU - Sens, D. AU - Chaikhouni, A. AU - Mais, D. AU - Halushka, P. V. PY - 1987 DA - 1987// TI - Cultured human vascular smooth muscle cells with functional thromboxane A2 receptors: measurement of U46619-induced 45calcium efflux JO - Circ Res VL - 60 UR - https://doi.org/10.1161/01.RES.60.6.952 DO - 10.1161/01.RES.60.6.952 ID - Dorn1987 ER - TY - JOUR AU - Pakala, R. AU - Willerson, J. T. AU - Benedict, C. R. PY - 1997 DA - 1997// TI - Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation JO - Circulation VL - 96 UR - https://doi.org/10.1161/01.CIR.96.7.2280 DO - 10.1161/01.CIR.96.7.2280 ID - Pakala1997 ER - TY - JOUR AU - FitzGerald, G. A. PY - 1991 DA - 1991// TI - Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists JO - Am J Cardiol VL - 68 UR - https://doi.org/10.1016/0002-9149(91)90379-Y DO - 10.1016/0002-9149(91)90379-Y ID - FitzGerald1991 ER - TY - JOUR AU - Ali, S. AU - Davis, M. G. AU - Becker, M. W. AU - Dorn, G. W. PY - 1993 DA - 1993// TI - Thromboxane A2 stimulates vascular smooth muscle hypertrophy by up-regulating the synthesis and release of endogenous basic fibroblast growth factor JO - J Biol Chem VL - 268 ID - Ali1993 ER - TY - JOUR AU - Hirata, M. PY - 1991 DA - 1991// TI - Cloning and expression of cDNA for a human thromboxane A2 receptor JO - Nature VL - 349 UR - https://doi.org/10.1038/349617a0 DO - 10.1038/349617a0 ID - Hirata1991 ER - TY - JOUR AU - Raychowdhury, M. K. PY - 1995 DA - 1995// TI - Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor JO - J Biol Chem VL - 270 UR - https://doi.org/10.1074/jbc.270.12.7011 DO - 10.1074/jbc.270.12.7011 ID - Raychowdhury1995 ER - TY - JOUR AU - Miggin, S. M. AU - Kinsella, B. T. PY - 1998 DA - 1998// TI - Expression and tissue distribution of the mRNAs encoding the human thromboxane A2 receptor (TP) alpha and beta isoforms JO - Biochim Biophys Acta VL - 1425 UR - https://doi.org/10.1016/S0304-4165(98)00109-3 DO - 10.1016/S0304-4165(98)00109-3 ID - Miggin1998 ER - TY - JOUR AU - Needleman, P. AU - Wyche, A. AU - Raz, A. PY - 1979 DA - 1979// TI - Platelet and blood vessel arachidonate metabolism and interactions JO - J Clin Invest VL - 63 UR - https://doi.org/10.1172/JCI109309 DO - 10.1172/JCI109309 ID - Needleman1979 ER - TY - JOUR AU - Cogolludo, A. AU - Moreno, L. AU - Bosca, L. AU - Tamargo, J. AU - Perez-Vizcaino, F. PY - 2003 DA - 2003// TI - Thromboxane A2-induced inhibition of voltage-gated K+ channels and pulmonary vasoconstriction: role of protein kinase Czeta JO - Circ Res VL - 93 UR - https://doi.org/10.1161/01.RES.0000095245.97945.FE DO - 10.1161/01.RES.0000095245.97945.FE ID - Cogolludo2003 ER - TY - JOUR AU - Sullivan, P. AU - Smyth, E. M. PY - 2002 DA - 2002// TI - Herterodimerization of the a and b isoforms of the human thromboxane receptor JO - Arterioscler Thromb Vasc Biol VL - 22 UR - https://doi.org/10.1161/01.ATV.0000023230.17493.E3 DO - 10.1161/01.ATV.0000023230.17493.E3 ID - Sullivan2002 ER - TY - JOUR AU - Powles, T. J. AU - Dowsett, M. AU - Easty, G. C. AU - Easty, D. M. AU - Neville, A. M. PY - 1976 DA - 1976// TI - Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin JO - Lancet VL - 307 UR - https://doi.org/10.1016/S0140-6736(76)90416-5 DO - 10.1016/S0140-6736(76)90416-5 ID - Powles1976 ER - TY - JOUR AU - Sung, S. PY - 2011 DA - 2011// TI - Overexpression of cyclooxygenase-2 in NCI-H292 human alveolar epithelial carcinoma cells: Roles of p38 MAPK, ERK-1/2, and PI3K/PKB signaling proteins JO - J Cell Biochem VL - 112 UR - https://doi.org/10.1002/jcb.23226 DO - 10.1002/jcb.23226 ID - Sung2011 ER - TY - JOUR AU - Kim, B. H. PY - 2011 DA - 2011// TI - Cyclooxygenase-2 overexpression in chronic inflammation associated with benign prostatic hyperplasia: is it related to apoptosis and angiogenesis of prostate cancer? JO - Korean J Urol VL - 52 UR - https://doi.org/10.4111/kju.2011.52.4.253 DO - 10.4111/kju.2011.52.4.253 ID - Kim2011 ER - TY - JOUR AU - Kulkarni, S. PY - 2001 DA - 2001// TI - Cyclooxygenase-2 Is Overexpressed in Human Cervical Cancer JO - Clin Cancer Res VL - 7 ID - Kulkarni2001 ER - TY - JOUR AU - Wang, M. AU - He, Y. AU - Shi, L. AU - Shi, C. PY - 2011 DA - 2011// TI - Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer JO - Eur J Gynaecol Oncol VL - XXXII ID - Wang2011 ER - TY - JOUR AU - Nie, D. PY - 2007 DA - 2007// TI - Cyclooxygenases and lipoxygenases in prostate and breast cancers JO - Front Biosci VL - 12 UR - https://doi.org/10.2741/2170 DO - 10.2741/2170 ID - Nie2007 ER - TY - STD TI - Park S-W: he influence of cyclooxygenase-1 expression on the efficacy of cyclooxygenase-2 inhibition in head and neck squamous cell carcinoma cell lines. Anti-Cancer Drugs. 22: 416-423. 10.1097/CAD.0b013e32834279f1. ID - ref81 ER - TY - JOUR AU - Langenbach, R. AU - Loftin, C. D. AU - Lee, C. AU - Tiano, H. PY - 1999 DA - 1999// TI - Cyclooxygenase-deficient Mice: A Summary of Their Characteristics and Susceptibilities to Inflammation and Carcinogenesis JO - Ann N Y Acad Sci VL - 889 UR - https://doi.org/10.1111/j.1749-6632.1999.tb08723.x DO - 10.1111/j.1749-6632.1999.tb08723.x ID - Langenbach1999 ER - TY - JOUR AU - Tiano, H. F. PY - 2002 DA - 2002// TI - Deficiency of Either Cyclooxygenase (COX)-1 or COX-2 Alters Epidermal Differentiation and Reduces Mouse Skin Tumorigenesis JO - Cancer Res VL - 62 ID - Tiano2002 ER - TY - JOUR AU - Rundhaug, J. E. AU - Mikulec, C. AU - Pavone, A. AU - Fischer, S. M. PY - 2007 DA - 2007// TI - A role for cyclooxygenase-2 in ultraviolet light-induced skin carcinogenesis JO - Mol Carcinog VL - 46 UR - https://doi.org/10.1002/mc.20329 DO - 10.1002/mc.20329 ID - Rundhaug2007 ER - TY - JOUR AU - Müller-Decker, K. PY - 2002 DA - 2002// TI - Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis JO - Proc Natl Acad Sci VL - 99 UR - https://doi.org/10.1073/pnas.192323799 DO - 10.1073/pnas.192323799 ID - Müller-Decker2002 ER - TY - JOUR AU - Liu, H. PY - 2011 DA - 2011// TI - COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer JO - Microvasc Res VL - 82 UR - https://doi.org/10.1016/j.mvr.2011.04.011 DO - 10.1016/j.mvr.2011.04.011 ID - Liu2011 ER - TY - JOUR AU - Williams, C. S. AU - Tsujii, M. AU - Reese, J. AU - Dey, S. K. AU - DuBois, R. N. PY - 2000 DA - 2000// TI - Host cyclooxygenase-2 modulates carcinoma growth JO - J Clin Invest VL - 105 UR - https://doi.org/10.1172/JCI9621 DO - 10.1172/JCI9621 ID - Williams2000 ER - TY - JOUR AU - Sales, K. J. AU - Boddy, S. C. AU - Williams, A. R. AU - Anderson, R. A. AU - Jabbour, H. N. PY - 2007 DA - 2007// TI - F-prostanoid receptor regulation of fibroblast growth factor 2 signaling in endometrial adenocarcinoma cells JO - Endocrinology VL - 148 UR - https://doi.org/10.1210/en.2006-1517 DO - 10.1210/en.2006-1517 ID - Sales2007 ER - TY - JOUR AU - Chu, J. AU - Lloyd, F. L. AU - Trifan, O. C. AU - Knapp, B. AU - Rizzo, M. T. PY - 2003 DA - 2003// TI - Potential Involvement of the Cyclooxygenase-2 Pathway in the Regulation of Tumor-associated Angiogenesis and Growth in Pancreatic Cancer1 JO - Mol Cancer Ther VL - 2 ID - Chu2003 ER - TY - JOUR AU - Chuang, H. C. AU - Kardosh, A. AU - Gaffney, K. J. AU - Petasis, N. A. AU - Schonthal, A. H. PY - 2008 DA - 2008// TI - COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro JO - Mol Cancer VL - 7 UR - https://doi.org/10.1186/1476-4598-7-38 DO - 10.1186/1476-4598-7-38 ID - Chuang2008 ER - TY - JOUR AU - Tegeder, I. AU - Pfeilschifter, J. AU - Geisslinger, G. PY - 2001 DA - 2001// TI - Cyclooxygenase-independent actions of cyclooxygenase inhibitors JO - FASEB J VL - 15 UR - https://doi.org/10.1096/fj.01-0390rev DO - 10.1096/fj.01-0390rev ID - Tegeder2001 ER - TY - JOUR AU - Khromova, N. AU - Kopnin, P. AU - Rybko, V. AU - Kopnin, B. P. PY - 2012 DA - 2012// TI - Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms JO - Oncogene VL - 31 UR - https://doi.org/10.1038/onc.2011.330 DO - 10.1038/onc.2011.330 ID - Khromova2012 ER - TY - JOUR AU - Schwarz-Cruz-y-Celis, A. PY - 2011 DA - 2011// TI - Cancer stem cells JO - Rev VL - 63 ID - Schwarz-Cruz-y-Celis2011 ER - TY - JOUR AU - Halamka, M. PY - 2011 DA - 2011// TI - Plasma levels of vascular endothelial growth factor during and after radiotherapy in combination with celecoxib in patients with advanced head and neck cancer JO - Oral Oncol VL - 47 UR - https://doi.org/10.1016/j.oraloncology.2011.05.009 DO - 10.1016/j.oraloncology.2011.05.009 ID - Halamka2011 ER - TY - JOUR AU - Yao, M. PY - 2003 DA - 2003// TI - Inhibition of Cyclooxygenase-2 by Rofecoxib Attenuates the Growth and Metastatic Potential of Colorectal Carcinoma in Mice JO - Cancer Res VL - 63 ID - Yao2003 ER - TY - JOUR AU - Wang, M. T. AU - Honn, K. V. AU - Nie, D. PY - 2007 DA - 2007// TI - Cyclooxygenases, prostanoids, and tumor progression JO - Cancer Metastasis Rev VL - 26 UR - https://doi.org/10.1007/s10555-007-9096-5 DO - 10.1007/s10555-007-9096-5 ID - Wang2007 ER - TY - JOUR AU - Muller-Decker, K. AU - Furstenberger, G. PY - 2007 DA - 2007// TI - The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis JO - Mol Carcinog VL - 46 UR - https://doi.org/10.1002/mc.20326 DO - 10.1002/mc.20326 ID - Muller-Decker2007 ER - TY - JOUR AU - Nakanishi, M. AU - Gokhale, V. AU - Meuillet, E. J. AU - Rosenberg, D. W. PY - 2010 DA - 2010// TI - mPGES-1 as a target for cancer suppression: A comprehensive invited review "Phospholipase A2 and lipid mediators" JO - Biochimie VL - 92 UR - https://doi.org/10.1016/j.biochi.2010.02.006 DO - 10.1016/j.biochi.2010.02.006 ID - Nakanishi2010 ER - TY - JOUR AU - Menter, D. G. AU - Schilsky, R. L. AU - DuBois, R. N. PY - 2010 DA - 2010// TI - Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-09-0788 DO - 10.1158/1078-0432.CCR-09-0788 ID - Menter2010 ER - TY - JOUR AU - Radmark, O. AU - Samuelsson, B. PY - 2010 DA - 2010// TI - Microsomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancer JO - J Intern Med VL - 268 ID - Radmark2010 ER - TY - JOUR AU - Nie, D. PY - 2004 DA - 2004// TI - Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility JO - Am J Pathol VL - 164 UR - https://doi.org/10.1016/S0002-9440(10)63133-1 DO - 10.1016/S0002-9440(10)63133-1 ID - Nie2004 ER - TY - JOUR AU - Osawa, T. PY - 2012 DA - 2012// TI - Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner JO - Cancer Sci VL - 103 UR - https://doi.org/10.1111/j.1349-7006.2012.02261.x DO - 10.1111/j.1349-7006.2012.02261.x ID - Osawa2012 ER - TY - JOUR AU - Wu, J. PY - 2011 DA - 2011// TI - Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway JO - J Biol Chem VL - 286 UR - https://doi.org/10.1074/jbc.M110.187344 DO - 10.1074/jbc.M110.187344 ID - Wu2011 ER - TY - JOUR AU - Timoshenko, A. V. AU - Xu, G. AU - Chakrabarti, S. AU - Lala, P. K. AU - Chakraborty, C. PY - 2003 DA - 2003// TI - Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells JO - Exp Cell Res VL - 289 UR - https://doi.org/10.1016/S0014-4827(03)00269-6 DO - 10.1016/S0014-4827(03)00269-6 ID - Timoshenko2003 ER - TY - JOUR AU - Yang, S. F. PY - 2010 DA - 2010// TI - Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells JO - J Biol Chem VL - 285 UR - https://doi.org/10.1074/jbc.M110.108183 DO - 10.1074/jbc.M110.108183 ID - Yang2010 ER - TY - JOUR AU - Ma, X. PY - 2010 DA - 2010// TI - Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities JO - Mol Cancer Res VL - 8 UR - https://doi.org/10.1158/1541-7786.MCR-10-0003 DO - 10.1158/1541-7786.MCR-10-0003 ID - Ma2010 ER - TY - JOUR AU - Hu, S. PY - 2013 DA - 2013// TI - Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis JO - Anticancer Drugs VL - 24 UR - https://doi.org/10.1097/CAD.0b013e32835a4dac DO - 10.1097/CAD.0b013e32835a4dac ID - Hu2013 ER - TY - JOUR AU - Holt, D. AU - Ma, X. AU - Kundu, N. AU - Fulton, A. PY - 2011 DA - 2011// TI - Prostaglandin E(2) (PGE (2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4 JO - Cancer Immunol Immunother VL - 60 UR - https://doi.org/10.1007/s00262-011-1064-9 DO - 10.1007/s00262-011-1064-9 ID - Holt2011 ER - TY - JOUR AU - Chen, Y. AU - Perussia, B. AU - Campbell, K. S. PY - 2007 DA - 2007// TI - Prostaglandin D2 suppresses human NK cell function via signaling through D prostanoid receptor JO - J Immunol VL - 179 UR - https://doi.org/10.4049/jimmunol.179.5.2766 DO - 10.4049/jimmunol.179.5.2766 ID - Chen2007 ER - TY - JOUR AU - Murata, T. PY - 2008 DA - 2008// TI - Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo JO - Proc Natl Acad Sci USA VL - 105 UR - https://doi.org/10.1073/pnas.0805171105 DO - 10.1073/pnas.0805171105 ID - Murata2008 ER - TY - JOUR AU - Wang, S. AU - Yang, Q. AU - Fung, K. M. AU - Lin, H. K. PY - 2008 DA - 2008// TI - AKR1C2 and AKR1C3 mediated prostaglandin D2 metabolism augments the PI3K/Akt proliferative signaling pathway in human prostate cancer cells JO - Mol Cell Endocrinol VL - 289 UR - https://doi.org/10.1016/j.mce.2008.04.004 DO - 10.1016/j.mce.2008.04.004 ID - Wang2008 ER - TY - JOUR AU - Keightley, M. C. AU - Sales, K. J. AU - Jabbour, H. N. PY - 2010 DA - 2010// TI - PGF2alpha-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer JO - BMC Cancer VL - 10 UR - https://doi.org/10.1186/1471-2407-10-488 DO - 10.1186/1471-2407-10-488 ID - Keightley2010 ER - TY - JOUR AU - Sales, K. J. PY - 2005 DA - 2005// TI - A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas JO - Cancer Res VL - 65 ID - Sales2005 ER - TY - JOUR AU - Schirner, M. AU - Kraus, C. AU - Lichtner, R. B. AU - Schneider, M. R. AU - Hildebrand, M. PY - 1998 DA - 1998// TI - Tumor metastasis inhibition with the prostacyclin analogue cicaprost depends on discontinuous plasma peak levels JO - Prostaglandins Leukot Essent Fatty Acids VL - 58 UR - https://doi.org/10.1016/S0952-3278(98)90041-2 DO - 10.1016/S0952-3278(98)90041-2 ID - Schirner1998 ER - TY - JOUR AU - Li, X. AU - Tai, H. H. PY - 2009 DA - 2009// TI - Activation of thromboxane A(2) receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells JO - Carcinogenesis VL - 30 UR - https://doi.org/10.1093/carcin/bgp161 DO - 10.1093/carcin/bgp161 ID - Li2009 ER - TY - JOUR AU - Turner, E. C. PY - 2011 DA - 2011// TI - Identification of an interaction between the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor with protein kinase C-related kinase (PRK) 1: implications for prostate cancer JO - J Biol Chem VL - 286 UR - https://doi.org/10.1074/jbc.M110.181180 DO - 10.1074/jbc.M110.181180 ID - Turner2011 ER - TY - JOUR AU - Moussa, O. PY - 2008 DA - 2008// TI - Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-6560 DO - 10.1158/0008-5472.CAN-07-6560 ID - Moussa2008 ER - TY - JOUR AU - Nie, D. PY - 2008 DA - 2008// TI - Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-1018 DO - 10.1158/0008-5472.CAN-07-1018 ID - Nie2008 ER - TY - JOUR AU - Liu, X. -. H. AU - Yao, S. AU - Kirschenbaum, A. AU - Levine, A. C. PY - 1998 DA - 1998// TI - NS398, a Selective Cyclooxygenase-2 Inhibitor, Induces Apoptosis and Down-Regulates bcl-2 Expression in LNCaP Cells JO - Cancer Res VL - 58 ID - Liu1998 ER - TY - JOUR AU - Xue, W. -. P. PY - 2011 DA - 2011// TI - Phase I clinical trial of nasopharyngeal radiotherapy and concurrent celecoxib for patients with locoregionally advanced nasopharyngeal carcinoma JO - Oral Oncol VL - 47 UR - https://doi.org/10.1016/j.oraloncology.2011.06.002 DO - 10.1016/j.oraloncology.2011.06.002 ID - Xue2011 ER - TY - JOUR AU - Seiz, M. PY - 2010 DA - 2010// TI - Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxib JO - Neurosurg Rev VL - 33 UR - https://doi.org/10.1007/s10143-010-0253-x DO - 10.1007/s10143-010-0253-x ID - Seiz2010 ER - TY - JOUR AU - Mao, J. T. PY - 2011 DA - 2011// TI - Lung cancer chemoprevention with celecoxib in former smokers JO - Cancer Prevention Res VL - 4 UR - https://doi.org/10.1158/1940-6207.CAPR-11-0078 DO - 10.1158/1940-6207.CAPR-11-0078 ID - Mao2011 ER - TY - JOUR AU - Koch, A. PY - 2011 DA - 2011// TI - Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group JO - Eur J Cancer VL - 47 UR - https://doi.org/10.1016/j.ejca.2011.03.035 DO - 10.1016/j.ejca.2011.03.035 ID - Koch2011 ER - TY - JOUR AU - Vinogradova, Y. AU - Coupland, C. AU - Hippisley-Cox, J. PY - 2011 DA - 2011// TI - Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case–control studies JO - Br J Cancer VL - 105 UR - https://doi.org/10.1038/bjc.2011.252 DO - 10.1038/bjc.2011.252 ID - Vinogradova2011 ER - TY - JOUR AU - Wang, J. PY - 2011 DA - 2011// TI - Prostacyclin administration as a beneficial supplement to the conventional cancer chemotherapy JO - Med Hypotheses VL - 76 UR - https://doi.org/10.1016/j.mehy.2011.01.036 DO - 10.1016/j.mehy.2011.01.036 ID - Wang2011 ER - TY - JOUR AU - Cuneo, K. C. AU - Fu, A. AU - Osusky, K. L. AU - Geng, L. PY - 2007 DA - 2007// TI - Effects of vascular endothelial growth factor receptor inhibitor SU5416 and prostacyclin on murine lung metastasis JO - Anticancer Drugs VL - 18 UR - https://doi.org/10.1097/CAD.0b013e328011fdab DO - 10.1097/CAD.0b013e328011fdab ID - Cuneo2007 ER - TY - JOUR AU - Griffoni, C. PY - 2007 DA - 2007// TI - Selective inhibition of prostacyclin synthase activity by rofecoxib JO - J Cell Mol Med VL - 11 UR - https://doi.org/10.1111/j.1582-4934.2007.00021.x DO - 10.1111/j.1582-4934.2007.00021.x ID - Griffoni2007 ER - TY - JOUR AU - Nakae, K. PY - 2005 DA - 2005// TI - A prostacyclin receptor antagonist inhibits the sensitized release of substance P from rat sensory neurons JO - J Pharmacol Exp Ther VL - 315 UR - https://doi.org/10.1124/jpet.105.091967 DO - 10.1124/jpet.105.091967 ID - Nakae2005 ER - TY - JOUR AU - Kaneshiro, T. PY - 2009 DA - 2009// TI - Inhibition of prostaglandin E(2) signaling through the EP(1) receptor does not affect prostacyclin production in human endothelial cells JO - Prostaglandins Other Lipid Mediat VL - 90 UR - https://doi.org/10.1016/j.prostaglandins.2009.07.003 DO - 10.1016/j.prostaglandins.2009.07.003 ID - Kaneshiro2009 ER - TY - JOUR AU - Ikawa, Y. AU - Fujino, H. AU - Otake, S. AU - Murayama, T. PY - 2012 DA - 2012// TI - Indomethacin antagonizes EP(2) prostanoid receptor activation in LS174T human colon cancer cells JO - Eur J Pharmacol VL - 680 UR - https://doi.org/10.1016/j.ejphar.2012.01.033 DO - 10.1016/j.ejphar.2012.01.033 ID - Ikawa2012 ER - TY - JOUR AU - Koeberle, A. PY - 2009 DA - 2009// TI - Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E(2) synthase-1 JO - Biochem Biophys Res Commun VL - 388 UR - https://doi.org/10.1016/j.bbrc.2009.08.005 DO - 10.1016/j.bbrc.2009.08.005 ID - Koeberle2009 ER - TY - JOUR AU - Hardtner, C. AU - Multhoff, G. AU - Falk, W. AU - Radons, J. PY - 2012 DA - 2012// TI - (−)-Epigallocatechin-3-gallate, a green tea-derived catechin, synergizes with celecoxib to inhibit IL-1-induced tumorigenic mediators by human pancreatic adenocarcinoma cells Colo357 JO - Eur J Pharmacol VL - 684 UR - https://doi.org/10.1016/j.ejphar.2012.03.039 DO - 10.1016/j.ejphar.2012.03.039 ID - Hardtner2012 ER - TY - JOUR AU - Watts, I. S. AU - Wharton, K. A. AU - White, B. P. AU - Lumley, P. PY - 1991 DA - 1991// TI - Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets JO - Br J Pharmacol VL - 102 UR - https://doi.org/10.1111/j.1476-5381.1991.tb12200.x DO - 10.1111/j.1476-5381.1991.tb12200.x ID - Watts1991 ER - TY - JOUR AU - Chouinard, M. L. PY - 1992 DA - 1992// TI - Pharmacokinetics and biochemical efficacy of pirmagrel, a thromboxane synthase inhibitor, in renal allograft recipients JO - Clin Pharmacol Ther VL - 52 UR - https://doi.org/10.1038/clpt.1992.197 DO - 10.1038/clpt.1992.197 ID - Chouinard1992 ER - TY - JOUR AU - Vermylen, J. PY - 1981 DA - 1981// TI - Thromboxane synthetase inhibition as antithrombotic strategy JO - Lancet VL - 1 UR - https://doi.org/10.1016/S0140-6736(81)92241-8 DO - 10.1016/S0140-6736(81)92241-8 ID - Vermylen1981 ER - TY - JOUR AU - Suehiro, T. PY - 1996 DA - 1996// TI - Thromboxane A2 in preservation-reperfusion injury: the effect of thromboxane A2 synthetase inhibitor JO - J Surg Res VL - 62 UR - https://doi.org/10.1006/jsre.1996.0198 DO - 10.1006/jsre.1996.0198 ID - Suehiro1996 ER - TY - JOUR AU - Oketani, K. AU - Inoue, T. AU - Murakami, M. PY - 2001 DA - 2001// TI - Effect of E3040, an inhibitor of 5-lipoxygenase and thromboxane synthase, on rat bowel damage induced by lipopolysaccharide JO - Eur J Pharmacol VL - 427 UR - https://doi.org/10.1016/S0014-2999(01)01234-1 DO - 10.1016/S0014-2999(01)01234-1 ID - Oketani2001 ER - TY - JOUR AU - Shi, H. PY - 1998 DA - 1998// TI - Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice JO - Eur Respir J VL - 11 ID - Shi1998 ER - TY - JOUR AU - Francis, H. P. AU - Greenham, S. J. AU - Patel, U. P. AU - Thompson, A. M. AU - Gardiner, P. J. PY - 1991 DA - 1991// TI - BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in the guinea-pig JO - Br J Pharmacol VL - 104 UR - https://doi.org/10.1111/j.1476-5381.1991.tb12475.x DO - 10.1111/j.1476-5381.1991.tb12475.x ID - Francis1991 ER - TY - JOUR AU - Navarro-Nunez, L. PY - 2008 DA - 2008// TI - Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway JO - J Agric Food Chem VL - 56 UR - https://doi.org/10.1021/jf0723209 DO - 10.1021/jf0723209 ID - Navarro-Nunez2008 ER - TY - JOUR AU - Guerrero, J. A. PY - 2007 DA - 2007// TI - Flavonoids inhibit the platelet TxA(2) signalling pathway and antagonize TxA(2) receptors (TP) in platelets and smooth muscle cells JO - Br J Clin Pharmacol VL - 64 UR - https://doi.org/10.1111/j.1365-2125.2007.02881.x DO - 10.1111/j.1365-2125.2007.02881.x ID - Guerrero2007 ER - TY - JOUR AU - Nakahata, N. PY - 2008 DA - 2008// TI - Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology JO - Pharmacol Ther VL - 118 UR - https://doi.org/10.1016/j.pharmthera.2008.01.001 DO - 10.1016/j.pharmthera.2008.01.001 ID - Nakahata2008 ER - TY - JOUR AU - Sung, Y. M. AU - He, G. AU - Fischer, S. M. PY - 2005 DA - 2005// TI - Lack of Expression of the EP2 but not EP3 Receptor for Prostaglandin E2 Results in Suppression of Skin Tumor Development JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-1015 DO - 10.1158/0008-5472.CAN-05-1015 ID - Sung2005 ER - TY - JOUR AU - Shoji, Y. PY - 2005 DA - 2005// TI - Prostaglandin E receptor EP3 deficiency modifies tumor outcome in mouse two-stage skin carcinogenesis JO - Carcinogenesis VL - 26 UR - https://doi.org/10.1093/carcin/bgi193 DO - 10.1093/carcin/bgi193 ID - Shoji2005 ER - TY - JOUR AU - Majima, M. AU - Amano, H. AU - Hayashi, I. PY - 2003 DA - 2003// TI - Prostanoid receptor signaling relevant to tumor growth and angiogenesis JO - Trends Pharmacol Sci VL - 24 UR - https://doi.org/10.1016/j.tips.2003.08.005 DO - 10.1016/j.tips.2003.08.005 ID - Majima2003 ER - TY - JOUR AU - Sales, K. J. AU - Milne, S. A. AU - Williams, A. R. W. AU - Anderson, R. A. AU - Jabbour, H. N. PY - 2004 DA - 2004// TI - Expression, localization, and signaling of prostaglandin F2α receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways JO - J Clin Endocrinol Metabol VL - 89 UR - https://doi.org/10.1210/jc.2003-031434 DO - 10.1210/jc.2003-031434 ID - Sales2004 ER - TY - JOUR AU - Clària, J. AU - Serhan, C. N. PY - 1995 DA - 1995// TI - Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions JO - Proc Natl Acad Sci VL - 92 UR - https://doi.org/10.1073/pnas.92.21.9475 DO - 10.1073/pnas.92.21.9475 ID - Clària1995 ER - TY - JOUR AU - Xu, X. C. AU - Liang, Z. AU - Song, S. AU - Menter, D. AU - Subbarayan, V. AU - Iyengar, S. AU - Tang, D. G. AU - Lippman, S. M. PY - 2003 DA - 2003// TI - Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398 JO - Neoplasia VL - 5 UR - https://doi.org/10.1016/S1476-5586(03)80003-9 DO - 10.1016/S1476-5586(03)80003-9 ID - Xu2003 ER - TY - JOUR AU - Mao, J. T. PY - 2004 DA - 2004// TI - Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-04-0945 DO - 10.1158/1078-0432.CCR-04-0945 ID - Mao2004 ER - TY - JOUR AU - Gao, Y. AU - Yokota, R. AU - Tang, S. AU - Ashton, A. W. AU - Ware, J. A. PY - 2000 DA - 2000// TI - Reversal of angiogenesis in vitro, induction of apoptosis, and inhibition of AKT phosphorylation in endothelial cells by thromboxane A(2) JO - Circ Res VL - 87 UR - https://doi.org/10.1161/01.RES.87.9.739 DO - 10.1161/01.RES.87.9.739 ID - Gao2000 ER - TY - JOUR AU - Williams, C. D. PY - 2011 DA - 2011// TI - A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer JO - Nutr Res VL - 31 UR - https://doi.org/10.1016/j.nutres.2011.01.002 DO - 10.1016/j.nutres.2011.01.002 ID - Williams2011 ER - TY - JOUR AU - Sapieha, P. PY - 2011 DA - 2011// TI - 5-Lipoxygenase Metabolite 4-HDHA Is a Mediator of the Antiangiogenic Effect of ω-3 Polyunsaturated Fatty Acids JO - Sci Transl Med VL - 3 UR - https://doi.org/10.1126/scitranslmed.3001571 DO - 10.1126/scitranslmed.3001571 ID - Sapieha2011 ER -